February 13-16, 2017
The conference brought together top researchers from around the world to share the latest studies, important developments, and best research methods in the ongoing battle against HIV/AIDS and related infectious diseases.
DNDi took part in an oral presentation on the superboosting approach for children co-infected with HIV and tuberculosis.
Lopinavir/Ritonavir 1:1 superboosting overcomes rifampicin interactions in children
* Presenting author